Skip to content

Chronic Obstructive Pulmonary Disease Markers and Prognosis

Three-years Follow-up of Diagnostic and Prognostic Markers in Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00605540
Enrollment
133
Registered
2008-01-31
Start date
2008-01-31
Completion date
2012-02-29
Last updated
2014-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD, Survival, Exacerbation, Disease markers

Brief summary

The study aim is to verify the association between the changes in markers of disease and patient´s prognosis in chronic obstructive pulmonary disease.

Detailed description

In a previous study, 133 COPD patients were followed-up during the period of one-year. Analyses of the association between baseline characteristic and the occurence of disease exacerbation was performed. In this study, the patients included in the previous research will be contacted and invited to participate in a complete evaluation after a three-year period. The association of the changes in dyspnea perception, spirometry variables, body composition, quality of life and exercise tolerance measures with disease prognostic will be studied.

Interventions

None listed

Sponsors

UPECLIN HC FM Botucatu Unesp
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* COPD diagnosis according to the GOLD criteria

Exclusion criteria

* Asthma * Inability to perform pulmonary function and exercise tolerance tests * Recent myocardial infarction or unstable angina * Congestive heart failure: class III/IV

Design outcomes

Primary

MeasureTime frameDescription
Forced Expiratory Volume in the First Second (FEV1)Baseline and after three yearsFEV1 values were measured by Spirometry using the KOKO Spirometer, before and 15 minutes after the inhalation of 400mcg of salbutamol.
Exercise ToleranceBaseline and after three yearsTolerance exercise was evaluated by six-minute walking distance(6MWD)according to the American Thoracic Society guidelines.Patients were instructed to walk, attempting to cover as much ground as possible within 6 min. A research assistant timed the walk, and standardized verbal encouragement was given.
Body CompositionBaseline and after three yearsBody composition was evaluated by Body Mass Index (BMI), which is dividing weight in kilograms by height in square meters.
DyspneaBaseline and after three yearsDyspnea was evaluated by Medical Research Council scale (MRC). MRC scale consists of only five items and it is based on activities that cause dyspnea. The patient reports the degree of dyspnea by choosing a value between 1 and 5. A higher number indicates greater sensation of dyspnea.
Health StatusBaseline and after three yearsSaint George's Respiratory Questionnaire (SGRQ)was used to evaluate patient's health status. SGRQ includes three domains: symptoms, activities and impact of the disease. Each domain has a minimum score (zero) and maximum (662.5, 1209.1, and 2117.8, respectively). A total score is also calculated based on the results of three domains, with a score maximum of 3989.4. The total score is referred to as the percentage achieved by the patient related to this maximum score. Minimum score means there is no impairment in the health status and high score means maximum dysfunction.

Countries

Brazil

Participant flow

Participants by arm

ArmCount
Chronic Obstructive Pulmonary Disease Markers Over Three Years
All patients were evaluated at baseline and attended at the clinics every six months for three years or until death.
133
Total133

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDeath15
Overall StudyLost to Follow-up23

Baseline characteristics

CharacteristicChronic Obstructive Pulmonary Disease Markers Over Three Years
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
67 Participants
Age, Categorical
Between 18 and 65 years
66 Participants
Age, Continuous64.8 years
STANDARD_DEVIATION 9.5
Region of Enrollment
Brazil
133 participants
Sex: Female, Male
Female
41 Participants
Sex: Female, Male
Male
92 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 133
serious
Total, serious adverse events
0 / 133

Outcome results

Primary

Body Composition

Body composition was evaluated by Body Mass Index (BMI), which is dividing weight in kilograms by height in square meters.

Time frame: Baseline and after three years

ArmMeasureGroupValue (MEDIAN)
Chronic Obstructive Pulmonary Disease Markers Over Three YearsBody CompositionBaseline assessment25 Kg/m^2
Chronic Obstructive Pulmonary Disease Markers Over Three YearsBody CompositionAfter three-year assessment25 Kg/m^2
Primary

Dyspnea

Dyspnea was evaluated by Medical Research Council scale (MRC). MRC scale consists of only five items and it is based on activities that cause dyspnea. The patient reports the degree of dyspnea by choosing a value between 1 and 5. A higher number indicates greater sensation of dyspnea.

Time frame: Baseline and after three years

ArmMeasureGroupValue (MEDIAN)
Chronic Obstructive Pulmonary Disease Markers Over Three YearsDyspneaBaseline assessment1 Scores on a scale
Chronic Obstructive Pulmonary Disease Markers Over Three YearsDyspneaAfter three-year assessment2 Scores on a scale
Primary

Exercise Tolerance

Tolerance exercise was evaluated by six-minute walking distance(6MWD)according to the American Thoracic Society guidelines.Patients were instructed to walk, attempting to cover as much ground as possible within 6 min. A research assistant timed the walk, and standardized verbal encouragement was given.

Time frame: Baseline and after three years

ArmMeasureGroupValue (MEAN)Dispersion
Chronic Obstructive Pulmonary Disease Markers Over Three YearsExercise ToleranceAfter three-year assessment412 metersStandard Deviation 100
Chronic Obstructive Pulmonary Disease Markers Over Three YearsExercise ToleranceBaseline assessment438 metersStandard Deviation 86
Primary

Forced Expiratory Volume in the First Second (FEV1)

FEV1 values were measured by Spirometry using the KOKO Spirometer, before and 15 minutes after the inhalation of 400mcg of salbutamol.

Time frame: Baseline and after three years

Population: The sampling frame for this study was consecutive COPD patients recruited from the outpatient clinic of Botucatu Medical School.

ArmMeasureGroupValue (MEDIAN)
Chronic Obstructive Pulmonary Disease Markers Over Three YearsForced Expiratory Volume in the First Second (FEV1)Baseline assessment54 Percentage predicted
Chronic Obstructive Pulmonary Disease Markers Over Three YearsForced Expiratory Volume in the First Second (FEV1)After three-year assessment54 Percentage predicted
Comparison: All data were analyzed using SigmaStat 3.2 (Inc., USA) software. Mean ± SD or median interquartile range (25-75%) was used depending on the data distribution. Wilcoxon test was applied to compare the characteristics at baseline to those observed after 3 years.p-value: 0.09Wilcoxon (Mann-Whitney)
Primary

Health Status

Saint George's Respiratory Questionnaire (SGRQ)was used to evaluate patient's health status. SGRQ includes three domains: symptoms, activities and impact of the disease. Each domain has a minimum score (zero) and maximum (662.5, 1209.1, and 2117.8, respectively). A total score is also calculated based on the results of three domains, with a score maximum of 3989.4. The total score is referred to as the percentage achieved by the patient related to this maximum score. Minimum score means there is no impairment in the health status and high score means maximum dysfunction.

Time frame: Baseline and after three years

ArmMeasureGroupValue (MEAN)Dispersion
Chronic Obstructive Pulmonary Disease Markers Over Three YearsHealth StatusBaseline assessment42 Percentage of total scoreStandard Deviation 19
Chronic Obstructive Pulmonary Disease Markers Over Three YearsHealth StatusAfter three-year assessment44 Percentage of total scoreStandard Deviation 19

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026